ReviewNPJ primary care respiratory medicine2021
Are smokers protected against SARS-CoV-2 infection (COVID-19)? The origins of the myth.
Review in NPJ primary care respiratory medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04915781 (Tobacco Use and Incidence of SARS-CoV-2 Infection in the Finnish General Population), which is not on this map. Cited by 41 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Tobacco Use and Incidence of SARS-CoV-2 Infection in the Finnish General Population
Who cites it
41 citing papers in PubMed.
- Conflation of prediction and causality in the TB literature.IJTLD open · 2025Article
- National and sub-national sero-epidemiology of immunoglobulin G against SARS-CoV-2 in Iran in 2021.PloS one · 2025Article
- Long-term effectiveness of an ultra-rapid rollout vaccination campaign with BNT162b2 on the incidence of SARS-CoV-2 infection.iScience · 2024Article
- E.Co.Tech Breathalyzer: A Pilot Study of a Non-invasive COVID-19 Diagnostic Tool for Light and Non-smokers.ACS measurement science au · 2024Article
- Similar Limited Protection Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Infection in Vaccinated Individuals With HIV and Comparable Controls.Open forum infectious diseases · 2024Article
- Can Intranasal Insulin and Cholinergic Agonist Improve Post-Covid-19 Cognition Impairment?Advanced pharmaceutical bulletin · 2024Article
- Case-control study of behavioural and societal risk factors for sporadic SARS-CoV-2 infections, Germany, 2020-2021 (CoViRiS study).Epidemiology and infection · 2024Article
- A Complex Interplay: Navigating the Crossroads of Tobacco Use, Cardiovascular Disease, and the COVID-19 Pandemic: A WHF Policy Brief.Global heart · 2024Review
- Association between biochemical and hematologic factors with COVID-19 using data mining methods.BMC infectious diseases · 2023Article
- Changes in prevalence and sociodemographic correlates of tobacco and nicotine use in Finland during the COVID-19 pandemic.European journal of public health · 2023Article
- COVID-19 and tobacco products use among US adults, 2021 National Health Interview Survey.Health science reports · 2023Article
- Incidence of SARS-CoV-2 infection and associated risk factors among staff and residents at homeless shelters in King County, Washington: an active surveillance study.Epidemiology and infection · 2023Article
- The predisposition of smokers to COVID-19 infection: A mini-review of global perspectives.Heliyon · 2023Review
- Use of data mining approaches to explore the association between type 2 diabetes mellitus with SARS-CoV-2.BMC pulmonary medicine · 2023Article
- Persistence of SARS-CoV-2 IgG Antibody Response among South African Adults: A Prospective Cohort Study.Vaccines · 2023Article
- Burden of long COVID among adults experiencing sheltered homelessness: a longitudinal cohort study in King County, WA between September 2020-April 2022.BMC public health · 2023Article
- Modifiable risk factors of COVID-19 in patients with multiple sclerosis: a single-centre case-control study.Journal of neurology · 2023Article
- "I'm Bored and I'm Stressed": A Qualitative Study of Exclusive Smokers, ENDS Users, and Transitioning Smokers or ENDS Users in the Time of COVID-19.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023Article
- Effect of smoking-related COVID-19 risk messaging on smoking cessation in community smokers: A pragmatic randomized controlled trial.Tobacco induced diseases · 2023Article
- Addressing Non-Communicable Diseases in Primary Healthcare in Kyrgyzstan: A Study on Population' Knowledge and Behavioral Changes.International journal of public health · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.